ATMEKSI

Metacel Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: Nov 21, 2025
Approval ID: 62de7345-613b-4838-96e5-aceca3cea6b2
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ATMEKSI® (methocarbamol) oral suspension safely and effectively. See full prescribing information for ATMEKSI (methocarbamol) oral suspension. ATMEKSI (methocarbamol) oral suspension Initial U.S. Approval: 05/07/2018

Quick Stats

Total Products1

Labelers1

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.